| 靶点: |
GI50: 9 nM (Src HuH7), 13 nM (Src PLC/PRF/5), 26 nM (Src Hep3B), 60 nM (Src HepG2) |
| 体内研究: |
Orally administered Tirbanibulin (KX2-391) is shown to inhibit primary tumor growth and to suppress metastasis, in pre-clinical animal models of cancer. |
| 保存条件: |
-80℃,充氩(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.982 ml |
9.912 ml |
19.824 ml |
| 5 mM |
0.396 ml |
1.982 ml |
3.965 ml |
| 10 mM |
0.198 ml |
0.991 ml |
1.982 ml |
| 50 mM |
0.04 ml |
0.198 ml |
0.396 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |